Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 100130-nm albumin-bound paclitaxel 34Oxaliplatin 28Capecitabine 27Fluorouracil 25Albumin-Bound Paclitaxel 23Leucovorin 19Irinotecan 18Erlotinib Hydrochloride 14Cyclophosphamide 12Radiosurgery 11pembrolizumab 10Radiotherapy 10Nivolumab 10Bevacizumab 10Surgical Procedures, Operative 9avelumab 7Docetaxel 7Taxes 6Cisplatin 6ruxolitinib 5folfirinox 5Specimen Handling 5Paclitaxel 5Everolimus 5Cetuximab 5ALT-803 5trametinib 4spartalizumab 4fludarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pancreatic Neoplasms × Clinical Laboratory Techniques × Clear all
NCT05523154 2025-02-18

"Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures

Mayo Clinic

Phase NA Terminated
8 enrolled 13 charts
Gastrointestinal

Pancreatic Neoplasms

NCT03137706 2021-04-05

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer

University of Southern California

Terminated
8 enrolled
Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡